Mixing Science and Politics

D.F. Dowd Joel Hirsch, an Israeli biochemist at Tel Aviv University, has one more thing to worry about when he submits a scientific paper for publication: the possibility that scientists who disagree with his country's policies will shun his work. "My nightmare scenario is that the paper gets sent to a reviewer who might have an axe to grind about Israeli scientists," Hirsch says. In the year since some British researchers called for a boycott of Israeli scientists, funding agencies have larg

Written byCatherine Zandonella
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Joel Hirsch, an Israeli biochemist at Tel Aviv University, has one more thing to worry about when he submits a scientific paper for publication: the possibility that scientists who disagree with his country's policies will shun his work. "My nightmare scenario is that the paper gets sent to a reviewer who might have an axe to grind about Israeli scientists," Hirsch says.

In the year since some British researchers called for a boycott of Israeli scientists, funding agencies have largely rejected such appeals. A subtler, possibly no less-damaging kind of boycott has surfaced, in which researchers express their outrage with the Israeli government by refusing to interact with Israeli scientists. As a result, when a talk is canceled, or a faculty member receives no reply from a European colleague, Israeli scientists can't help but think the worst. "I can't be sure if it was because I am Israeli," says Orly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies